P1339: CLINICAL OUTCOMES OF PATIENTS WITH EBV+ PTLD FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION WHO FAIL RITUXIMAB: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY

P1339: CLINICAL OUTCOMES OF PATIENTS WITH EBV+ PTLD FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION WHO FAIL RITUXIMAB: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY

Bibliographic Details
Main Authors:	J. Sanz-Caballer, J. Storek, G. Socié, D. Thirumalai, N. Guzman-Beccera, P. Xun, D. Kumar, N. Sadetsky, D. Dierickx, J. Reitan, A. Barlev, M. Mohty
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000848220.74181.5a

Similar Items

P1107: CLINICAL OUTCOMES OF SOLID ORGAN TRANSPLANT PATIENTS WITH EBV+ PTLD WHO FAIL RITUXIMAB PLUS CHEMOTHERAPY: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY
by: V. Dharnidharka, et al.
Published: (2022-06-01)

P1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF-THE-SHELF EBV-SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES
by: S. Choquet, et al.
Published: (2022-06-01)

P1390: NEW AND UPDATED RESULTS FROM A MULTICENTER OPEN-LABEL GLOBAL PHASE3 STUDY OF TAB-CEL FOR EBV+PTLD FOLLOWING HCT OR SOT AFTER FAILURE OF RITUXIMAB OR RITUXIMAB+CHEMOTHERAPY (ALLELE)
by: Mahadeo Kris Michael, et al.
Published: (2023-08-01)

P1388: EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH ALLOGENEIC EBV-SPECIFIC T-CELL IMMUNOTHERAPY (TABELECLEUCEL) UNDER AN EXPANDED ACCESS PROGRAM IN EUROPE
by: Sylvain Choquet, et al.
Published: (2023-08-01)

Use of Foscarnet Therapy for EBV Infection following Control of PTLD with Enhancement of Cellular Immunity in a Lung-Transplant Recipient
by: Kamyar Afshar, et al.
Published: (2011-01-01)

Post-transplantation lymphoproliferative disorders (PTLD) localized in the central nervous system: Report from an international survey on PTLD
by: Hossein Khedmat, et al.
Published: (2013-01-01)

Lymph Node Flow Cytometry as a Prompt Recognition of Ultra Early Onset PTLD: A Successful Case of Rituximab Treatment
by: Xiaofan Li, et al.
Published: (2015-01-01)

Navigating Epstein–Barr Virus (EBV) and Post-Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Liver Transplantation: Current Knowledge and Strategies for Treatment and Surveillance
by: Erin Y. Chen, et al.
Published: (2025-02-01)

A case of post renal transplant PTLD of lung
by: Tanay Sinha, et al.
Published: (2023-01-01)

Jean des Murs’s Canones tabularum Alfonsii of 1339
by: Nothaft, CPE
Published: (2019)

PTLD Burkitt Lymphoma in a Patient with Remote Lymphomatoid Granulomatosis
by: A. Stravodimou, et al.
Published: (2012-01-01)

P1346: EVALUATION OF CURRENT NATIONAL PRACTICE IN THE PREVENTION OF PTLD POST PAEDIATRIC HSCT
by: E. Kissane, et al.
Published: (2022-06-01)

PD‐L1 and PD1 expression in post‐transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter‐ and intra‐individual descriptive study covering the whole spectrum of PTLD categories
by: Ana‐Iris Schiefer, et al.
Published: (2019-08-01)

Effectiveness of the toxicant DRC‐1339 in reducing populations of common ravens in Wyoming
by: Luke W. Peebles, et al.
Published: (2016-06-01)

Hypolipidemic action of Rutin on Triton WR-1339 induced hyperlipidemia in rats
by: Livingston Raja NR, et al.
Published: (2021-05-01)

Effects of ludartin and grosshemin on experimental hyperlipidemia induced by triton WR 1339
by: A. V. Ratkin, et al.
Published: (2015-12-01)

EBV Infection in XLP1 Manifested Solely by Behavioral Aggression and Effective Treatment Using Rituximab
by: Michelle M. Korah-Sedgwick, et al.
Published: (2018-01-01)

Impact of prophylaxis with rituximab on EBV-related complications after allogeneic hematopoietic cell transplantation in children
by: Agata Marjańska, et al.
Published: (2024-07-01)

The Post-transplant Lymphoproliferative Disorders—Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) Study Methods and Protocol
by: Vikas R. Dharnidharka, MD, MPH, et al.
Published: (2024-11-01)

PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
by: Chowdhury, F, et al.
Published: (2009)

Longitudinal analysis of the impact of rituximab on circulating EBV miRNAs in three paediatric kidney transplant recipients
by: Jaythoon Hassan, et al.
Published: (2024-02-01)

Successful treatment of an EBV‐positive HIV‐associated polymorphic B‐cell lymphoproliferative disorder by rituximab monotherapy
by: Mohamad Sabbah, et al.
Published: (2021-08-01)

Effects of Moschus Herbal-acupuncture on Hyperlipidemia Rats induced by Triton WR-1339
by: Kyung-Sun Soh, et al.
Published: (2003-02-01)

Late Onset Graft Plasmacytoma-Like PTLD Presenting as Acute Hyperglycemia in a Kidney-Pancreas Transplant Recipient
by: P. Ventura-Aguiar, et al.
Published: (2019-01-01)

Transplanted patient with late post-transplant linfoproliferative disease (PTLD) and graft collapsing glomerulopathy
by: Luciano Leguizamón, et al.
Published: (2016-03-01)

The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD)
by: Xavier Badia, et al.
Published: (2024-08-01)

Synoptic analysis of atmospheric pattern of the most pervasive cold day in Iran from 1339 to 1388
by: Hossein Asakereh, et al.
Published: (2018-09-01)

Evaluation of the hypolipidemic effect of cinnamon essential oil in a model of acute damage induced by triton WR-1339
by: JM De la Rosa-García, et al.
Published: (2022-12-01)

CAR‐T Cell Therapy for PTLD: Analysis of CAR‐T Product, Engraftment, and Outcomes in Patients Receiving Parallel Immunosuppression
by: Aikaterini Panopoulou, et al.
Published: (2025-02-01)

RELATO DE CASO – DOENÇA LINFOPROLIFERATIVA PÓS-TRANSPLANTE (PTLD): OS DESAFIOS DO DIAGNÓSTICO À TERAPÊUTICA
by: MD Costa, et al.
Published: (2024-10-01)

A prognostic model, including the EBV status of tumor cells, for primary gastric diffuse large B‐cell lymphoma in the rituximab era
by: Eri Ishikawa, et al.
Published: (2018-07-01)

S256: TABELECLEUCEL FOR EBV-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL OR SOLID ORGAN TRANSPLANT AFTER FAILURE OF RITUXIMAB ± CHEMOTHERAPY (ALLELE)
by: S. Prockop, MD, et al.
Published: (2022-06-01)

Antioxidant and Hyperlipidemia Effect of Ganoderma Lucidum Fungus Alcoholic Extract in Male Albino Rats Using Tritonwr 1339
by: Husain AL- Obaidy, et al.
Published: (2019-06-01)

P1339: IMPACT OF CLONAL HEMATOPOIESIS AND CANAKINUMAB ON NON-HEMATOLOGICAL MALIGNANCY: ANALYSIS OF THE CANTOS RANDOMIZED CLINICAL TRIAL
by: Janghee Woo, et al.
Published: (2023-08-01)

Metabolomics analysis delineates the therapeutic effects of Yinlan Tiaozhi capsule on triton WR-1339 -induced hyperlipidemia in mice
by: Guanlin Xiao, et al.
Published: (2023-10-01)

High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD
by: Julien Lupo, et al.
Published: (2022-08-01)

Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)
by: Kathryn Kline, et al.
Published: (2023-08-01)

Hepatitis B virus infection has no significant role on lymphoproliferative disorders post liver transplantation: PTLD. int survey
by: Morteza Izadi, Dr., et al.
Published: (2011-07-01)

EBV & lymphoma
by: Dolores Caballero, (Coordinating Author)
Published: (2019-06-01)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
by: Yi Tian Png, et al.
Published: (2021-02-01)